PAOLONI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 120
EU - Europa 72
AS - Asia 52
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 262
Nazione #
US - Stati Uniti d'America 120
IT - Italia 33
CN - Cina 21
SG - Singapore 17
CI - Costa d'Avorio 12
HK - Hong Kong 10
IE - Irlanda 9
SE - Svezia 7
FR - Francia 5
DE - Germania 4
FI - Finlandia 4
AT - Austria 3
MA - Marocco 3
CH - Svizzera 2
GB - Regno Unito 2
IN - India 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BO - Bolivia 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
Totale 262
Città #
Des Moines 25
Chandler 23
Boardman 13
Abidjan 12
Hong Kong 10
Singapore 10
Dublin 9
Xi'an 6
Macerata 5
Wilmington 5
Arnold 4
Helsinki 4
New York 4
Ningbo 4
Tolentino 3
Fairfield 2
Falls Church 2
Lawrence 2
Milan 2
Nuremberg 2
Orange 2
Princeton 2
Pune 2
San Diego 2
San Mateo 2
Sant'Egidio alla Vibrata 2
Seattle 2
Stuttgart 2
Turin 2
Vienna 2
Woodbridge 2
Zurich 2
Ancona 1
Ann Arbor 1
Ashburn 1
Bolton 1
Boston 1
Chicago 1
Florence 1
Guangzhou 1
Houston 1
Huizhou 1
Jiaxing 1
La Paz 1
London 1
Phoenix 1
Shanghai 1
Tokyo 1
Wuhan 1
Totale 188
Nome #
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 73
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 65
85P NSCLC-Pro ClustAI: A machine learning model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 40
NSCLC-Pro ClustAI: A Machine Learning Model to prognostically stratify patients with advanced NSCLC treated with immune checkpoint inhibitors 37
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 34
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 15
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers 15
Totale 279
Categoria #
all - tutte 1.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.623


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 8 1
2021/202224 0 2 0 0 1 3 1 1 5 1 3 7
2022/202374 5 8 4 4 0 29 0 4 13 1 5 1
2023/202468 4 0 0 0 2 6 0 0 0 6 13 37
2024/2025104 31 18 20 4 9 8 14 0 0 0 0 0
Totale 279